💼 Business 1d ago · Jaimy Lee

Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss

MarketWatch
MarketWatch business
View Channel →
Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss
Source ↗ 👁 2 💬 0
Several medical studies have found that people taking GLP-1 medications have an elevated risk for nonarteritic anterior ischemic optic neuropathy, or NAION.

Comments (0)

Sign in to join the discussion

More Like This

IRS raises 2027 standard deduction and child tax credit in its annual inflation adjustments
Business – Hartford Courant · 1h ago
Frontier Airlines adds first-class seating, extra-legroom options
Business – Hartford Courant · 1h ago
Should you trust new AI agents with your money and data?
NPR Topics: Business · 3h ago
Stocks fall as the 10-year Treasury yield nears 5% mark
MarketWatch.com - Top Stories · 3h ago
How the stock market has performed after Veterans Day over the past decade
MarketWatch.com - Top Stories · 3h ago
📰
Fossil CEO says turnaround is ahead of plan as sales return to growth
Business News · 3h ago